| LAT | Local Ablative Therapies |
| ECT | Electrochemotherapy |
| CRC | Colorectal Cancer |
| ESMO | European Society of Medical Oncology |
| RFA | Radiofrequency ablation |
| MWA | Microwave ablation |
| CRYO | Cryoablation |
| TAE | Transarterial therapies |
| TACE | Transarterial chemoembolization |
| ESOPE | European Standard Operating Procedure for Electrochemotherapy |
| CR | Complete Response |
| PR | Partial Response |
| PD | Progression Disease |
| SD | Stable Disease |
| ORR | Overall response rate |
| HCC | Hepatocellular carcinoma |
| BRCA | Breast Carcinoma |
| OS | Overall survival |
| CT | Computed tomography |
| CEIS | Contrast enhanced ultrasound |
| PHCCA | Perihilar cholangiocarcinoma |
| LTC | Local tumour control |
| NSCLC | Non-Small Cell Lung Carcinoma |
| TARE | Radioembolization |
| PFS | Progression free survival |
| HIPEC | Hyperthermic Intraperitoneal chemotherapy |
| IM | Intrahepatic metastases |
| PM | Intraperitoneal metastases |